Corbus Pharmaceuticals Holdings

CRBP

$7.70

Name : Corbus Pharmaceuticals Holdings

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $142,664,032.00

EPSttm : -5.74

Corbus Pharmaceuticals Holdings

$7.70

1.85%

$0.14

CRBP — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

7.23

Margin Of Safety %

Put/Call OI Ratio

0.05

EPS Next Q Diff

0.2

EPS Last/This Y

1.34

EPS This/Next Y

-0.51

Price

7.66

Target Price

36.5

Analyst Recom

Performance Q

-23.31

Upside

-1,080.9%

Beta

2.59

Ticker: CRBP

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	CRBP	11.04	0.15	0.01	22778
2026-05-12	CRBP	11.45	0.14	0.00	23699
2026-05-13	CRBP	12.2	0.14	0.00	24343
2026-05-14	CRBP	12.03	0.13	0.01	25124
2026-05-15	CRBP	11	0.13	0.23	25017
2026-05-18	CRBP	9.92	0.02	0.01	20517
2026-05-19	CRBP	9.1	0.02	0.01	20595
2026-05-20	CRBP	9.75	0.02	0.00	21376
2026-05-21	CRBP	11.53	0.02	0.02	22126
2026-05-22	CRBP	11.34	0.02	0.00	23600
2026-05-26	CRBP	7.9	0.02	0.04	23601
2026-05-27	CRBP	7.8	0.04	0.02	35564
2026-05-28	CRBP	7.68	0.04	0.15	35560
2026-05-29	CRBP	7.9	0.04	0.23	35889
2026-06-02	CRBP	7.54	0.05	0.11	36121
2026-06-03	CRBP	7.38	0.05	0.01	36155
2026-06-04	CRBP	8.01	0.05	0.12	36125
2026-06-05	CRBP	7.57	0.05	0.23	36260
2026-06-08	CRBP	7.55	0.05	0.00	36316
2026-06-09	CRBP	7.69	0.05	0.00	36346
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	CRBP	11.03	12.2	-25.3	-4.56
2026-05-12	CRBP	11.47	12.2	-45.6	-4.56
2026-05-13	CRBP	12.19	12.2	-52.2	-4.56
2026-05-14	CRBP	12.01	12.2	-11.4	-4.56
2026-05-15	CRBP	11.03	12.2	5.5	-4.57
2026-05-18	CRBP	9.93	13.6	14.0	-4.57
2026-05-19	CRBP	9.11	13.6	9.1	-4.57
2026-05-20	CRBP	9.75	14.1	-48.2	-4.65
2026-05-21	CRBP	11.54	14.1	-92.2	-4.65
2026-05-22	CRBP	11.34	14.1	-10.9	-4.65
2026-05-26	CRBP	7.91	14.1	70.5	-4.65
2026-05-27	CRBP	7.80	14.1	9.0	-4.65
2026-05-28	CRBP	7.66	14.1	25.4	-4.65
2026-05-29	CRBP	7.91	14.1	-69.6	-4.65
2026-06-01	CRBP	7.74	14.1	24.2	-4.57
2026-06-02	CRBP	7.55	14.1	29.8	-4.57
2026-06-03	CRBP	7.38	14.1	118.1	-4.57
2026-06-04	CRBP	8.03	14.1	-442.5	-4.57
2026-06-05	CRBP	7.58	14.1	52.4	-4.57
2026-06-08	CRBP	7.57	14.1	-5.8	-4.57
2026-06-09	CRBP	7.66	14.1	-74.5	-4.57
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	CRBP	-3.43	18.56	8.40
2026-05-12	CRBP	-3.43	18.56	8.79
2026-05-13	CRBP	-3.43	18.56	8.79
2026-05-14	CRBP	-3.43	18.56	8.79
2026-05-15	CRBP	-3.29	18.56	8.42
2026-05-18	CRBP	-3.29	17.97	8.42
2026-05-19	CRBP	-3.29	17.97	8.42
2026-05-20	CRBP	-3.28	17.97	8.42
2026-05-21	CRBP	-3.28	17.97	8.49
2026-05-22	CRBP	-3.04	17.97	8.49
2026-05-26	CRBP	-3.04	-1.42	8.51
2026-05-27	CRBP	-3.01	-1.42	8.51
2026-05-28	CRBP	-3.01	-1.42	7.23
2026-05-29	CRBP	-3.00	-1.42	7.23
2026-06-02	CRBP	-3.00	-1.95	7.23
2026-06-03	CRBP	-3.00	-1.95	7.23
2026-06-04	CRBP	-2.36	-1.95	7.23
2026-06-05	CRBP	-2.36	-1.95	7.23
2026-06-08	CRBP	-2.36	-1.95	7.23
2026-06-09	CRBP	-2.34	-1.95	7.23
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-1.23

Avg. EPS Est. Current Quarter

-1.24

Avg. EPS Est. Next Quarter

-1.03

Insider Transactions

-2.34

Institutional Transactions

-1.95

Beta

2.59

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

88.9

Max Drawdown 5-Year %

-96.8

Target Price

36.5

P/E

Forward P/E

PEG

P/S

P/B

1.08

P/Free Cash Flow

EPS

-5.81

Average EPS Est. Cur. Y

-4.57

EPS Next Y. (Est.)

-5.07

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.72

Return on Equity vs Sector %

-94.4

Return on Equity vs Industry %

-78.2

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.01

EBIT Estimation

-74.5

◆ CRBP Healthcare

$7.70

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

19/25

Volume

9/15

Valuation

12/20

TP/AR

2/10

Options

8/10

RSI

39.3

Range 1M

10.8%

Sup Dist

3.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

12/30

Estimates

0/20

Inst/Vol

0/15

Options

6/10

EPS Yr

21.3%

EPS NY

-10.9%

52W%

7.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +374% upside

Quality

2/30

Valuation

16/30

Growth

8/25

Stability

7/10

LT Trend

1/5

Upside

+374%

Quality

Corbus Pharmaceuticals Holdings

Sector: Healthcare

Industry: Biotechnology

Employees: 36

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.

CRBP

Latest News

—

Caricamento notizie per CRBP…

stock quote shares CRBP – Corbus Pharmaceuticals Holdings, Inc. Stock Price stock today

news today CRBP – Corbus Pharmaceuticals Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CRBP – Corbus Pharmaceuticals Holdings, Inc. yahoo finance google finance

stock history CRBP – Corbus Pharmaceuticals Holdings, Inc. invest stock market

stock prices CRBP premarket after hours

ticker CRBP fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CRBP

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y